company-logo

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.

Achilles Therapeutics Dividend Announcement

Achilles Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Achilles Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Achilles Therapeutics Dividend History

Achilles Therapeutics Dividend Yield

Achilles Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Achilles Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Achilles Therapeutics Financial Ratios

P/E ratio-0.63
PEG ratio0.01
P/B ratio0.41
ROE-54.57%
Payout ratio0.00%
Current ratio6.04
Quick ratio6.04
Cash Ratio4.66

Achilles Therapeutics Dividend FAQ

Does Achilles Therapeutics stock pay dividends?
Achilles Therapeutics does not currently pay dividends to its shareholders.
Has Achilles Therapeutics ever paid a dividend?
No, Achilles Therapeutics has no a history of paying dividends to its shareholders. Achilles Therapeutics is not known for its dividend payments.
Why doesn't Achilles Therapeutics pay dividends?
There are several potential reasons why Achilles Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Achilles Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Achilles Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Achilles Therapeutics a dividend aristocrat?
Achilles Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Achilles Therapeutics a dividend king?
Achilles Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Achilles Therapeutics a dividend stock?
No, Achilles Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Achilles Therapeutics stocks?
To buy Achilles Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Achilles Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.